Lupiximab 100

Lupiximab 100 is a prescription injectable medicine containing Rituximab 100 mg in 10 mL, shown as a Lupin product. It is a r-DNA monoclonal antibody medicine used under specialist supervision for selected blood cancers and autoimmune conditions. Big serious injection, because apparently one small vial needs the authority of an entire hospital committee.

Rituximab is commonly used in conditions such as Non-Hodgkin’s Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis, Granulomatosis with Polyangiitis, and Microscopic Polyangiitis, depending on the doctor’s diagnosis and treatment plan.

Composition:

Rituximab – 100 mg / 10 mL

Key Information:

Brand Name: Lupiximab 100
Strength: 100 mg / 10 mL
Active Ingredient: Rituximab
Dosage Form: Injection / concentrate for solution for infusion
Medicine Type: Monoclonal antibody / Immunotherapy / CD20-directed therapy
Manufacturer/Brand Shown: Lupin
Common Use: Treatment of selected blood cancers and autoimmune disorders
Other Prescribed Uses: NHL, CLL, Rheumatoid Arthritis, GPA, MPA, and other specialist-directed uses
Administration: Intravenous infusion only
Category: Prescription medicine
Pack Size: Single-use vial

How It Works:

Lupiximab 100 works by targeting CD20, a protein found on certain B-cells. These B-cells may be involved in some cancers and autoimmune diseases. Rituximab binds to CD20-positive B-cells and helps the body remove them through immune mechanisms.

Potential Indications:

• Non-Hodgkin’s Lymphoma, also called NHL
• Chronic Lymphocytic Leukemia, also called CLL
• Rheumatoid Arthritis
• Granulomatosis with Polyangiitis
• Microscopic Polyangiitis
• Other doctor-directed use based on diagnosis and reports

Dosage & Storage:

Use only as directed by a qualified healthcare professional.
Rituximab injection should be given as an intravenous infusion by trained medical staff.
Do not self-administer this medicine.
Store strictly as per the product label and hospital pharmacy cold-chain instructions.
Keep out of reach of children.

Important Safety Information:

Rituximab should be used carefully under strict medical supervision, especially in patients with infection risk, hepatitis B history, heart problems, lung problems, low blood counts, or previous infusion reactions. Rituximab products can cause serious infusion reactions and severe skin or mouth reactions, so monitoring during and after infusion is important.

Possible side effects may include:

• Fever
• Chills
• Headache
• Nausea
• Weakness or tiredness
• Rash or itching
• Low blood pressure during infusion
• Breathing difficulty
• Increased risk of infections
• Low blood cell counts

Serious symptoms such as breathing difficulty, severe rash, mouth ulcers, fever, confusion, weakness, unusual infections, or severe infusion reaction symptoms should be reported to a doctor immediately.

Label Verification:

Please double-check the physical product label before listing or use, including the product name, strength, active ingredient, manufacturer details, batch number, expiry date, storage instructions, dosage directions, route of administration, and packaging information.

General Information Disclaimer:

The information provided here is for general educational and product-identification purposes only. It should not be considered medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before starting, stopping, or changing any medication regimen.